About BTG International
BTG International is a Healthcare company based in London (United Kingdom) founded in 1948, and was acquired by Boston Scientific in November 2018. Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments. The company has 1 employees. BTG International has completed 7 acquisitions, including Biocompatibles, EKOS Corporation and Galil Medical. BTG International offers products and services including Defibrillators, Pacemakers, and Spinal Cord Stimulators. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is BTG INTERNATIONAL LIMITED.
Company details
BTG International was founded in 1948 in London, United Kingdom, within the pharmaceuticals sector. Therapeutic agents are developed for disorders including neurological conditions, varicose veins, liver cancer, blood clots, and emphysema. Operations span three segments: Interventional Medicine, covering oncology products like TheraSphere, vascular treatments such as Varithena, and pulmonology options like PneumRx Coil. Antidote products, including CroFab for snake envenomations and DigiFab for digoxin toxicity, are also provided.
- Headquarters London, United Kingdom
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Website btgplc.com
- Social LinkedIn
- Acquired by Boston Scientific (Nov 2018)
- Legal Name Btg International Limited
- Date of Incorporation 14 Nov, 1991
- Jurisdiction FARNHAM, SURREY
- Annual Revenue$173.79 M (USD)7as on Dec 31, 2020
- Net Profit$58.14 M (USD)11as on Dec 31, 2020
- Latest Funding Round$5.5M (USD), Post-IPO
Jan 2011
- InvestorsBoston Scientific
& 1 more
- Employee Count1
- Investments & AcquisitionsBiocompatibles
& 6 more
- Acquired byBoston Scientific
(Nov 2018)
Products & Services of BTG International
BTG International offers a comprehensive portfolio of products and services, including Defibrillators, Pacemakers, and Spinal Cord Stimulators.
Devices that treat cardiac arrhythmias and save lives.
Implants that regulate heart rhythm for patients.
Systems that alleviate chronic pain through stimulation.
Funding Insights of BTG International
- Total Rounds 6
- Last Round Post-IPO β $5.5M
- First Round $336,875
(May 2008)
- Investors Count 1
All 6 funding rounds of BTG International with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in BTG International
BTG International has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Boston Scientific and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for BTG International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BTG International
1150 people are tracked at BTG International (315 in leadership, 9 in board & advisors, 826 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Augusto Chaves | IT PMO & Finance Head | Leadership |
Genevieve Morrison | IT Director, Acquisition & Integrations | Leadership |
David Sapienza | VP Global Operation Distribution And Logistics | Leadership |
Nikunj Murgai | Director, IT | Leadership |
Jodi Eddy | Senior Vice President, Enterprise Services and Digital Officer | Leadership |
Siri Thompson | Vice President, Program Management LAAC | Leadership |
Lance Bates | SVP & President, Interventional Cardiology Therapies | Leadership |
Alex Pflugfelder | Director - Upstream EP Marketing, EP Commercial Development Team | Leadership |
Sofía Leiva | HR Specialist - People Services Partner Latam | Leadership |
Zoe Heuver | Supply Chain Partner | Leadership |
Charles K. | Director, Quality | Leadership |
Ahmed Abdelaal | Chief Medical Officer | Leadership |
Lillian Kerrigan | Director Global Quality Design Controls And Acquisitions | Leadership |
Viktoriya Skuz | People Partner I | Leadership |
Kelly Schwenn | Director Of Program Management, Arden Hills And North America Manufacturing | Leadership |
Charudatta Aradhye | Associate Director, R&D | Leadership |
Sandra Nagale | Director, Digital Health Products, Platforms & AI | Leadership |
Gary Leblanc | Director Of Quality | Leadership |
Janet Bukovcan | Director, Regulatory Affairs | Leadership |
Philip Sinclair | Vice President, Global Medical Affairs And Clinical Development, Interventional Oncology | Leadership |
1130 more people are available in the full profile.
Complete people profiles for BTG International
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BTG International
BTG International has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biocompatibles, EKOS Corporation and Galil Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Obstetric device developed to prevent childbirth infections. | novatemedical.com | New Orleans, United States | 2010 | Sep 2018 | $20M | |
Inferior vena cava filters are developed for pulmonary embolism treatment. | novate.biz | Galway, Ireland | 2006 | Sep 2018 | $150M | |
Catheters for interventional cardiology in arterial disease are developed. | roxwoodmedical.com | Redwood, United States | 2011 | Oct 2017 | $80M | |
A platform offering an online slot game for entertainment. | galilmedical.com | Arden Hills, United States | 1996 | May 2016 | $84.5M | |
Minimally invasive emphysema treatments using Nitinol lung coils are developed. | pneumrx.com | Mountain View, United States | 2004 | Dec 2014 | $230M | |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. | ekoscorp.com | Bothell, United States | 1995 | May 2013 | $180M | |
UK-based biotherapeutics company developing products for the treatment of liver and HCC cancer. | biocompatibles.com | Farnham, United Kingdom | 1998 | Nov 2010 | β’β’β’β’ |
Complete acquisition details for BTG International
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BTG International
12 dated milestones of BTG International across 70 years, from founding to its latest funding, stage changes and deals.
- Founded BTG International is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $337K.
- Acquisition Acquires Biocompatibles.
- Funding Latest funding round, Post-IPO, of $5.5M.
- Acquisition Acquires EKOS Corporation.
- Acquisition Acquires PneumRx.
- Acquisition Acquires Galil Medical.
- Acquisition Acquires Roxwood Medical.
- Acquisition Acquires Novate Medical.
- Acquisition Acquires Novate.
- Exit Acquired by Boston Scientific.
Web traffic of BTG International
Websites that share an audience with BTG International (btgplc.com).
Websites whose visitors overlap most with BTG International. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| astrazeneca.com | 100% | 1.3M | #48,983 | View details | |
| amgen.com | 79% | 495.4K | #116,434 | View details | |
| inovio.com | 77% | 11.7K | #1,670,423 | View details | |
| ipsen.com | 76% | 112.9K | #336,868 | View details | |
novartis.net | novartis.net | 76% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for BTG International
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Btg International
Complete news archive for BTG International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BTG International
BTG International was founded in 1948 and raised its 1st funding round 60 years after it was founded.
BTG International is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
BTG International has 1 employees.
Annual revenue of BTG International is $173.79M as on Dec 31, 2020.
BTG International was founded in 1948 in London, United Kingdom, within the pharmaceuticals sector. Therapeutic agents are developed for disorders including neurological conditions, varicose veins, liver cancer, blood clots, and emphysema. Operations span three segments: Interventional Medicine, covering oncology products like TheraSphere, vascular treatments such as Varithena, and pulmonology options like PneumRx Coil. Antidote products, including CroFab for snake envenomations and DigiFab for digoxin toxicity, are also provided.
BTG International offers Defibrillators, Pacemakers, and Spinal Cord Stimulators.
BTG International has made 7 acquisitions, including Biocompatibles, EKOS Corporation, and Galil Medical.
BTG International has 2 investors. Key investors include Boston Scientific, and HHS.
BTG International operates through Btg International Limited.
Yes. BTG International was acquired by Boston Scientific in November 2018.

